فانجارد بي لقاح السعال الديكي الفموي الحي المضعف للكلاب بورديتيلا برونكيسيبتيكا
Vanguard B is an avirulent live culture of Bordetella bronchiseptica for oral administration to dogs. Indicated for the vaccination of healthy dogs 8 weeks of age or older as an aid in preventing canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica, stimulating rapid mucosal immunity in the oropharynx.
Dosage Form
N/A
Product Type
Biological
Manufacturer
Package
Cartons of 25 x 1-dose vials with sterile diluent and oral applicator tips
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 1 mL administered orally into the buccal pouch | Oral (buccal pouch instillation) | Single 1 mL oral dose for healthy dogs 8 weeks of age or older; revaccinate annually |
No withdrawal information available.
Vaccination of healthy dogs 8 weeks of age or older as an aid in preventing canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica.
Do not inject subcutaneously or intramuscularly (oral use only). Do not administer concurrently with systemic antibacterial agents.
If accidentally injected subcutaneously, severe abscess or systemic reaction may occur; treat with antibiotics.
Mild transient sneezing, coughing, or oral hypersensitivity.
Vanguard B Oral Kennel Cough Vaccine Prescribing Information
LeafletNo diseases linked.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.